3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting clinical attention due to limited evidence suggesting distinct pharmacological properties. Preliminary studies demonstrate https://www.pinterest.com/pin/1140888518124046392/